These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21331688)

  • 1. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.
    Park J; Cho HK; Moon JI
    Jpn J Ophthalmol; 2011 Jan; 55(1):22-7. PubMed ID: 21331688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
    Inoue K; Shiokawa M; Wakakura M; Tomita G
    J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.
    Choi HY; Lee JE; Lee JW; Park HJ; Lee JE; Jung JH
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):146-52. PubMed ID: 22107041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
    Eisenberg DL; Toris CB; Camras CB
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.
    Honrubia F; García-Sánchez J; Polo V; de la Casa JM; Soto J
    Br J Ophthalmol; 2009 Mar; 93(3):316-21. PubMed ID: 19019922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost.
    Nakakura S; Tabuchi H; Kiuchi Y
    Optom Vis Sci; 2011 Sep; 88(9):1140-4. PubMed ID: 21666524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse periocular reactions to five types of prostaglandin analogs.
    Inoue K; Shiokawa M; Higa R; Sugahara M; Soga T; Wakakura M; Tomita G
    Eye (Lond); 2012 Nov; 26(11):1465-72. PubMed ID: 23037910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periocular changes in topical bimatoprost and latanoprost use.
    Karslioğlu MZ; Hoşal MB; Tekeli O
    Turk J Med Sci; 2015; 45(4):925-30. PubMed ID: 26422869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
    Schwartz GF; Tan J; Kotak S
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.
    Frenkel RE; Frenkel M; Toler A
    BMC Ophthalmol; 2007 Sep; 7():16. PubMed ID: 17900371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.
    Zhong Y; Shen X; Yu J; Tan H; Cheng Y
    Cornea; 2011 Aug; 30(8):861-4. PubMed ID: 21499083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Parrish RK; Palmberg P; Sheu WP;
    Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
    Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study.
    Kammer JA; Katzman B; Ackerman SL; Hollander DA
    Br J Ophthalmol; 2010 Jan; 94(1):74-9. PubMed ID: 19726422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost.
    Aihara M; Shirato S; Sakata R
    Jpn J Ophthalmol; 2011 Nov; 55(6):600-4. PubMed ID: 21953485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.